Weekly Endocrinology Research Analysis
This week’s endocrinology literature highlights mechanistic discoveries with clear translational potential and population-level risk markers. Genome-wide CRISPR and in vivo QTL mapping nominate Golgi trafficking and PDIA6 as central regulators of proinsulin homeostasis, offering new β‑cell therapeutic targets. Complementary animal and human studies show obesity can directly induce reversible hypothyroidism and identify adipocyte oxytocin signaling as a driver of milk lipid mobilization, reshapin
Summary
This week’s endocrinology literature highlights mechanistic discoveries with clear translational potential and population-level risk markers. Genome-wide CRISPR and in vivo QTL mapping nominate Golgi trafficking and PDIA6 as central regulators of proinsulin homeostasis, offering new β‑cell therapeutic targets. Complementary animal and human studies show obesity can directly induce reversible hypothyroidism and identify adipocyte oxytocin signaling as a driver of milk lipid mobilization, reshaping endocrine paradigms. Several cohort and multi-omics studies also advance noninvasive biomarkers and diagnostic models for metabolic liver disease, hypertension risk, and endocrine etiologies.
Selected Articles
1. Proinsulin regulators identified with CRISPR screen and in vivo mouse QTL mapping.
A genome-wide CRISPR screen in β-cell lines identified 84 regulators of the intracellular proinsulin/insulin ratio and, when integrated with mouse plasma proinsulin QTL mapping, converged on Golgi trafficking as a central control axis and PDIA6 as a top convergent regulator. PDIA6 knockdown reduced proinsulin accumulation in Golgi/secretory granules without altering folding, impairing proinsulin production through a UPR-independent mechanism. Cross-species perturbations support PDIA6 and Golgi-trafficking as actionable targets for restoring proinsulin/insulin balance.
Impact: Provides a validated, mechanism-rich atlas of proinsulin regulation that nominates PDIA6 and Golgi-trafficking pathways as novel, actionable targets for β-cell dysfunction in diabetes — a high-impact mechanistic advance with translational potential.
Clinical Implications: PDIA6/Golgi-trafficking modulation may enable therapies that normalize proinsulin/insulin balance and improve glycemic control; these targets warrant validation in human islets and diabetic models and could inform biomarker development.
Key Findings
- Genome-wide CRISPR screen identified 84 regulators of intracellular proinsulin/insulin ratio.
- Functional annotation highlights Golgi trafficking as primary organelle axis controlling proinsulin storage and levels.
- Mouse QTL mapping converged on PDIA6; PDIA6 knockdown reduced Golgi/secretory granule proinsulin and impaired production via a UPR-independent mechanism.
2. Overnutrition in mice impairs thyroid hormone biosynthesis and utilization, causing hypothyroidism, despite remarkable thyroidal adaptations.
Diet-induced overnutrition in mice produced rapid, reversible hypothyroidism within weeks by lowering thyroidal T3/T4 and thyroglobulin, inducing ER stress and suppressing peripheral T4 activation (deiodination), which reduced energy expenditure. Despite histological and vascular expansion of the thyroid, functional impairment occurred and was reversible with weight loss; human BMI correlated with thyroid vascularization, suggesting translational relevance.
Impact: Challenges the prevailing causality assumption (that hypothyroidism causes obesity) by showing obesity can directly induce hypothyroidism via dual hits on biosynthesis and activation, a paradigm-shifting insight with implications for managing obesity-related thyroid dysfunction.
Clinical Implications: Clinicians should recognize obesity as a potential driver of thyroid dysfunction, interpret thyroid tests in the context of adiposity, and prioritize weight loss as a potentially restorative intervention; further human studies to define biomarkers (e.g., thyroid vascular indices, deiodinase activity) are warranted.
Key Findings
- Overnutrition induced hypothyroidism within 3 weeks in mice with decreased thyroidal T3/T4 and thyroglobulin and evidence of ER stress.
- Thyroid glands showed marked histological and vascular expansion despite impaired function—suggesting maladaptive remodeling.
- Peripheral T4 activation (deiodinase activity) was suppressed, producing T4 resistance and reduced energy expenditure; dysfunction was reversible with weight loss and correlates with human BMI-related vascular changes.
3. Oxytocin signaling in adipocytes is required for normal milk fat production.
In adipocyte-specific OXTR knockout dams, loss of oxytocin signaling impaired adipose lipolysis, reducing milk triglyceride supply and compromising neonatal growth, demonstrating that adipose tissue lipolysis—driven by oxytocin—substantially contributes to milk fat provision during lactation. The study shifts focus from mammary epithelial synthesis alone to a systemic endocrine circuit involving adipose tissue.
Impact: Identifies a novel endocrine circuit—oxytocin-driven adipose lipolysis—that is essential for milk fat provision and neonatal growth, opening new mechanistic and therapeutic avenues in lactation biology and potential causes of lactation failure.
Clinical Implications: Although preclinical, findings suggest assessing maternal oxytocin–adipose pathways in lactation insufficiency and exploring targeted modulation of lipolysis or OXT signaling as potential therapies to improve milk fat content.
Key Findings
- Adipocyte-specific OXTR deletion impairs lipid mobilization necessary for milk triglyceride supply.
- Oxytocin’s role in lactation extends beyond mammary de novo lipogenesis to include adipose lipolysis.
- Neonatal growth depends on dam adipose-derived triglyceride mobilization via oxytocin signaling.